Geode Capital Management’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $698K | Buy |
|
|||||
|
2025
Q3 | $373K | Buy |
|
|||||
|
2025
Q2 | $68K | Sell |
|
|||||
|
2025
Q1 | $215K | Buy |
|
|||||
|
2024
Q4 | $246K | Sell |
|
|||||
|
2024
Q3 | $474K | Sell |
|
|||||
|
2024
Q2 | $468K | Sell |
|
|||||
|
2024
Q1 | $962K | Buy |
|
|||||
|
2023
Q4 | $852K | Buy |
|
|||||
|
2023
Q3 | $2.54M | Buy |
|
|||||
|
2023
Q2 | $3.14M | Buy |
|
|||||
|
2023
Q1 | $3.12M | Buy |
|
|||||
|
2022
Q4 | $3.91M | Buy |
|
|||||
|
2022
Q3 | $5.96M | Buy |
|
|||||
|
2022
Q2 | $2.15M | Buy |
|
|||||
|
2022
Q1 | $3.71M | Buy |
|
|||||
|
2021
Q4 | $6.96M | Buy |
|
|||||
|
2021
Q3 | $12.9M | Buy |
|
|||||
|
2021
Q2 | $8.52M | Buy |
|
|||||
|
2021
Q1 | $10M | Buy |
|
|||||
|
2020
Q4 | $11.9M | Buy |
|
|||||
|
2020
Q3 | $8.22M | Buy |
|